Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Cell cycle and apoptosis regulator 1, CCAR1, regulates enhancer-dependent nuclear receptor CAR transactivation.

Kanno Y, Zhao S, Yamashita N, Saito N, Ujiie A, Iijima R, Kikawa N, Nemoto K, Inouye Y.

Mol Pharmacol. 2018 Nov 5. pii: mol.118.114272. doi: 10.1124/mol.118.114272. [Epub ahead of print]

2.

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients.

Terawaki H, Hayashi T, Murase T, Iijima R, Waki K, Tani Y, Nakamura T, Yoshimura K, Uchida S, Kazama JJ.

Oxid Med Cell Longev. 2018 Jul 8;2018:9714710. doi: 10.1155/2018/9714710. eCollection 2018.

3.

Sensitive Analysis of Sialic Acid and Related Compound by Hydrophilic Interaction Liquid Chromatography Using Fluorescence Detection after Derivatization with DBD-PZ.

Kawasaki A, Yasuda M, Mawatari KI, Fukuuchi T, Yamaoka N, Kaneko K, Iijima R, Yui S, Satoh M, Nakagomi K.

Anal Sci. 2018;34(7):841-844. doi: 10.2116/analsci.18N001.

4.

Clinical Outcomes of Drug-Coated Balloons in Coronary Artery Disease Unsuitable for Drug-Eluting Stent Implantation.

Iijima R, Kougame N, Hara H, Moroi M, Nakamura M.

Circ J. 2018 Jul 25;82(8):2025-2031. doi: 10.1253/circj.CJ-18-0121. Epub 2018 Jun 12.

5.

Congenital Absence of Left Atrial Appendage Diagnosed by Multimodality Imaging.

Enomoto Y, Hashimoto G, Sahara N, Hashimoto H, Niikura H, Nakamura K, Iijima R, Hara H, Suzuki M, Noro M, Moroi M, Sugi K, Nakamura M.

Int Heart J. 2018 Mar 30;59(2):439-442. doi: 10.1536/ihj.17-094. Epub 2018 Mar 12.

6.

Serial assessment of endothelial vasomotor function using optimal medical therapy predicts clinical outcomes in patients after complete coronary revascularization.

Tokue M, Iijima R, Moroi M, Nakamura M.

Anatol J Cardiol. 2018 Mar;19(3):177-183. doi: 10.14744/AnatolJCardiol.2018.47568.

7.

Vascular response to biolimus A-9 eluting stent in patients with shorter and prolonged dual antiplatelet therapy: optical coherence tomography sub-study of the NIPPON trial.

Kuroda K, Shinke T, Otake H, Kinutani H, Iijima R, Ako J, Okada H, Ito Y, Ando K, Anzai H, Tanaka H, Ueda Y, Takiuchi S, Nishida Y, Ohira H, Kawaguchi K, Kadotani M, Niinuma H, Omiya K, Morita T, Zen K, Yasaka Y, Inoue K, Ishiwata S, Ochiai M, Hamasaki T, Urasawa K, Kataoka T, Yoshiyama M, Fujii K, Inoue T, Kawata M, Yokoi H, Nakamura M; NIPPON investigators.

Heart Vessels. 2018 Aug;33(8):837-845. doi: 10.1007/s00380-018-1131-7. Epub 2018 Feb 20.

8.

Uric Acid in the Follow-Up Determines 30% Decline in Estimated GFR Over 2 Years: a Propensity Score Analysis.

Chang WX, Xu N, Kumagai T, Iijima R, Waki K, Yamanaka M, Nagura M, Arai S, Tamura Y, Shibata S, Fujigaki Y, Uchida S.

Kidney Blood Press Res. 2017;42(6):1053-1067. doi: 10.1159/000485593. Epub 2017 Dec 4.

9.

Author`s Reply.

Niikura H, Iijima R.

Anatol J Cardiol. 2018 Jan;19(1):79-80. No abstract available.

10.

Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.

Iijima R, Watanabe T, Ishiuchi K, Matsumoto T, Watanabe J, Makino T.

J Ethnopharmacol. 2018 Mar 25;214:153-159. doi: 10.1016/j.jep.2017.12.016. Epub 2017 Dec 14.

PMID:
29248449
11.

Paget-Schroetter Syndrome Resulting from Thoracic Outlet Syndrome and KAATSU Training.

Noto T, Hashimoto G, Takagi T, Awaya T, Araki T, Shiba M, Iijima R, Hara H, Moroi M, Nakamura M, Sugi K.

Intern Med. 2017 Oct 1;56(19):2595-2601. doi: 10.2169/internalmedicine.7937-16. Epub 2017 Sep 6.

12.

Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapy.

Nakamura M, Kougame N, Iijima R, Ono T, Ikeda N, Tokue M, Hayashi F, Watanabe M, Takenaka H, Fukui R, Hara H.

J Cardiol. 2017 Dec;70(6):511-517. doi: 10.1016/j.jjcc.2017.06.003. Epub 2017 Aug 2. Review.

PMID:
28780077
13.

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure.

Niikura H, Iijima R, Anzai H, Kogame N, Fukui R, Takenaka H, Kobayashi N.

Anatol J Cardiol. 2017 Sep;18(3):206-212. doi: 10.14744/AnatolJCardiol.2017.7628. Epub 2017 Aug 2.

14.

Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation.

Nakamura M, Iijima R, Ako J, Shinke T, Okada H, Ito Y, Ando K, Anzai H, Tanaka H, Ueda Y, Takiuchi S, Nishida Y, Ohira H, Kawaguchi K, Kadotani M, Niinuma H, Omiya K, Morita T, Zen K, Yasaka Y, Inoue K, Ishiwata S, Ochiai M, Hamasaki T, Yokoi H; NIPPON Investigators.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1189-1198. doi: 10.1016/j.jcin.2017.04.019.

15.

Synthesis, Electronic Structure, and Reactivities of Two-Sulfur-Stabilized Carbones Exhibiting Four-Electron Donor Ability.

Morosaki T, Iijima R, Suzuki T, Wang WW, Nagase S, Fujii T.

Chemistry. 2017 Jun 27;23(36):8694-8702. doi: 10.1002/chem.201700863. Epub 2017 May 5.

PMID:
28337803
16.
17.

A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis.

Iijima R, Ndrepepa G, Kujath V, Harada Y, Kufner S, Schunkert H, Nakamura M, Kastrati A.

Heart Vessels. 2017 Apr;32(4):376-384. doi: 10.1007/s00380-016-0889-8. Epub 2016 Aug 24.

PMID:
27557547
18.

Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents.

Iijima R, Nakamura M, Matsuyama Y, Muramatsu T, Yokoi H, Hara H, Okada H, Ochiai M, Suwa S, Hozawa H, Kawai K, Awata M, Mukawa H, Fujita H, Nanto S; J-DESsERT.

Am J Cardiol. 2016 Sep 15;118(6):790-796. doi: 10.1016/j.amjcard.2016.06.050. Epub 2016 Jul 1.

PMID:
27544742
19.

Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.

Ndrepepa G, Iijima R, Kufner S, Braun S, Cassese S, Byrne RA, Sorges J, Schulz-Schüpke S, Hoppmann P, Fussaro M, Laugwitz KL, Schunkert H, Kastrati A.

Am Heart J. 2016 Jul;177:9-16. doi: 10.1016/j.ahj.2016.03.016. Epub 2016 May 6.

PMID:
27297844
20.

Utility of the SYNTAX score in predicting outcomes after coronary intervention for chronic total occlusion.

Nagashima Y, Iijima R, Nakamura M, Sugi K.

Herz. 2015 Dec;40(8):1090-6. doi: 10.1007/s00059-015-4323-2. Epub 2015 Jul 2.

PMID:
26135461
21.

High-sensitivity cardiac troponin T level is associated with angiographic complexity of coronary artery disease: a cross-sectional study.

Yamazaki K, Iijima R, Nakamura M, Sugi K.

Heart Vessels. 2016 Jun;31(6):890-6. doi: 10.1007/s00380-015-0689-6. Epub 2015 May 12.

PMID:
25964074
22.

Impact of glycemic variability in patients with ST-elevated myocardial infarction.

Tokue M, Iijima R, Imamura T, Niikura H, Hayashi F, Yazaki Y, Nagashima Y, Yamazaki K, Ono T, Hara H, Nakamura M, Sugi K.

Int J Cardiol. 2015;187:660-2. doi: 10.1016/j.ijcard.2015.03.365. Epub 2015 Mar 27. No abstract available.

PMID:
25880405
23.

Prediction of Development of Critical Limb Ischemia in Hemodialysis Patients.

Yoshikawa H, Iijima R, Hashimoto G, Hara H, Omae K, Yoshikawa Y, Suzuki M, Nakamura M, Sugi K, Yoshikawa M.

Ther Apher Dial. 2015 Aug;19(4):378-84. doi: 10.1111/1744-9987.12287. Epub 2015 Mar 25.

PMID:
25810351
24.

Percutaneous antegrade mitral paravalvular leak closure through porcelain atrial septum- first percutaneous paravalvular leak closure in Japan.

Hara H, Matsumoto Y, Matsumoto T, Kar S, Hashimoto G, Araki T, Nagashima Y, Yamazaki K, Tokue M, Enomoto Y, Hayashi F, Yazaki Y, Iijima R, Suzuki M, Sugi K, Nakamura M.

Circ J. 2015;79(4):894-6. doi: 10.1253/circj.CJ-14-0940. Epub 2015 Jan 26. No abstract available.

25.

SYNTAX score predicts major bleeding following drug-eluting stent implantation in an all-comers population.

Iijima R, Nagashima Y, Sato K, Tokue M, Araki T, Yamazaki K, Shiba M, Hara H, Sugi K, Nakamura M.

Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):54-62. doi: 10.1016/j.rec.2014.02.028. Epub 2014 Aug 22.

PMID:
25155630
27.

Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome.

Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M, Ikeda N, Makino K, Itaya H, Iijima R, Hara H, Takagi T, Joki N, Sugi K, Nakamura M.

Am J Cardiol. 2014 May 15;113(10):1647-51. doi: 10.1016/j.amjcard.2014.02.019. Epub 2014 Mar 2.

PMID:
24656479
28.

Bronchogenic cyst compressing the superior vena cava and the left atrium.

Yoshikawa H, Suzuki M, Iijima R, Nakamura M, Sugi K.

Eur Heart J Cardiovasc Imaging. 2014 Jul;15(7):831. doi: 10.1093/ehjci/jeu002. Epub 2014 Jan 30. No abstract available.

PMID:
24480242
29.

Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.

Enomoto Y, Iijima R, Tokue M, Ito N, Nagashima Y, Araki T, Yamazaki K, Utsunomiya M, Hori M, Itaya H, Shiba M, Hara H, Nakamura M, Sugi K.

Cardiovasc Interv Ther. 2014 Jul;29(3):193-9. doi: 10.1007/s12928-013-0234-4. Epub 2013 Dec 24.

PMID:
24366503
30.

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale.

Inazawa T, Sakamoto K, Kohro T, Iijima R, Kitazawa T, Hirano T, Kawamura M, Tagami M, Tanaka A, Mori Y, Yamazaki T, Shiba T; RESEARCH Study Group.

Lipids Health Dis. 2013 Oct 5;12:142. doi: 10.1186/1476-511X-12-142.

31.

Development of a fluorescence analysis method for N-acetylneuraminic acid and its oxidized product ADOA.

Ota T, Yasuda M, Iijima R, Yui S, Fukuuchi T, Yamaoka N, Mawatari K, Kaneko K, Nakagomi K.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:152-7. doi: 10.1016/j.jchromb.2013.06.003. Epub 2013 Jun 20.

PMID:
23831708
32.

Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation.

Iijima R, Araki T, Nagashima Y, Yamazaki K, Utsunomiya M, Hori M, Itaya H, Shinji H, Shiba M, Hara H, Nakamura M, Sugi K.

Int J Cardiol. 2013 Oct 3;168(3):2588-92. doi: 10.1016/j.ijcard.2013.03.046. Epub 2013 Apr 8.

PMID:
23578895
33.

Acteoside inhibits type Ι allergy through the down-regulation of Ca/NFAT and JNK MAPK signaling pathways in basophilic cells.

Motojima H, Villareal MO, Iijima R, Han J, Isoda H.

J Nat Med. 2013 Oct;67(4):790-8. doi: 10.1007/s11418-013-0753-4. Epub 2013 Mar 15.

PMID:
23494816
34.

Impact of carotid artery ultrasound and ankle-brachial index on prediction of severity of SYNTAX score.

Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K.

Circ J. 2013;77(3):712-6. Epub 2012 Nov 10.

35.

Successful treatment of a common hepatic artery pseudoaneurysm using a coronary covered stent following pancreatoduodenectomy: report of a case.

Asai K, Watanabe M, Kusachi S, Matsukiyo H, Saito T, Kodama H, Enomoto T, Nakamura Y, Okamoto Y, Saida Y, Iijima R, Nagao J.

Surg Today. 2014 Jan;44(1):160-5. doi: 10.1007/s00595-012-0314-6. Epub 2012 Aug 30.

PMID:
22932840
36.

Glycated hemoglobin is associated with the complexity of coronary artery disease, even in non-diabetic adults.

Ikeda N, Iijima R, Hara H, Moroi M, Nakamura M, Sugi K.

J Atheroscler Thromb. 2012;19(12):1066-72. Epub 2012 Aug 9.

37.

AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.

Mizuno S, Iijima R, Ogishima S, Kikuchi M, Matsuoka Y, Ghosh S, Miyamoto T, Miyashita A, Kuwano R, Tanaka H.

BMC Syst Biol. 2012 May 30;6:52. doi: 10.1186/1752-0509-6-52.

38.

On delayed discrete evolutionary dynamics.

Iijima R.

J Theor Biol. 2012 May 7;300:1-6. doi: 10.1016/j.jtbi.2012.01.001. Epub 2012 Jan 18.

PMID:
22266122
40.

Carotid artery intima-media thickness and plaque score can predict the SYNTAX score.

Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K.

Eur Heart J. 2012 Jan;33(1):113-9. doi: 10.1093/eurheartj/ehr399. Epub 2011 Oct 25.

PMID:
22028386
41.
42.

Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up).

Ikeda N, Nakajima R, Utsunomiya M, Hori M, Itaya H, Makino K, Ono T, Yamamoto M, Nemoto N, Iijima R, Hara H, Takagi T, Hara H, Nakamura M, Sugi K.

Heart Vessels. 2011 Sep;26(5):495-501. doi: 10.1007/s00380-010-0083-3. Epub 2011 Jan 7.

PMID:
21213110
43.

Relationship between renal function stage and clinical outcomes after paclitaxel-eluting stent implantation.

Yazaki Y, Iijima R, Nakamura M, Sugi K.

J Cardiol. 2011 Jan;57(1):61-8. doi: 10.1016/j.jjcc.2010.10.005. Epub 2010 Dec 10.

44.

A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function.

Ikeda N, Nakamura M, Yazaki Y, Ono T, Yamamoto M, Ito S, Yokouchi I, Yajima S, Iijima R, Hara H, Takagi T, Hara H, Asahara T, Sakai H, Sugi K.

Heart Vessels. 2011 Sep;26(5):473-9. doi: 10.1007/s00380-010-0080-6. Epub 2010 Nov 26.

PMID:
21110196
45.
46.

Inhibitory effect of acteoside isolated from Cistanche tubulosa on chemical mediator release and inflammatory cytokine production by RBL-2H3 and KU812 cells.

Yamada P, Iijima R, Han J, Shigemori H, Yokota S, Isoda H.

Planta Med. 2010 Oct;76(14):1512-8. doi: 10.1055/s-0030-1249775. Epub 2010 Mar 30.

PMID:
20354949
47.

Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.

Takasawa Y, Iijima R, Shiba M, Nakamura M, Sugi K.

J Cardiol. 2010 May;55(3):391-6. doi: 10.1016/j.jjcc.2010.01.003. Epub 2010 Feb 7.

48.

Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation.

Hayashi F, Iijima R, Nakamura M, Sugi K.

J Cardiol. 2010 Jan;55(1):34-40. doi: 10.1016/j.jjcc.2009.08.002. Epub 2009 Sep 19.

49.

Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.

Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Itaya H, Shiba M, Wada M, Iijima R, Yamamoto M, Yamamoto M, Hara H, Takagi T, Asahara T, Mitsuo K, Kobayashi N, Sugi K.

Ther Adv Cardiovasc Dis. 2009 Oct;3(5):357-65. doi: 10.1177/1753944709338893. Epub 2009 Jul 28.

PMID:
19638365
50.

Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress.

Abe S, Tsunashima R, Iijima R, Yamada T, Maruyama N, Hisajima T, Abe Y, Oshima H, Yamazaki M.

Microbiol Immunol. 2009 Jun;53(6):323-30. doi: 10.1111/j.1348-0421.2009.00128.x.

Supplemental Content

Loading ...
Support Center